ZLAB Stock: Price, Forecast, Financials & AI Analysis

Loading chart...

High

25.250

Open

25.250

VWAP

24.57

Vol

1.42M

Mkt Cap

2.70B

Low

24.010

Amount

34.99M

EV/EBITDA(TTM)

Total Shares

110.64M

2.25B

EV/OCF(TTM)

P/S(TTM)

5.88

Zai Lab Ltd is a holding company primarily engaged in biopharmaceutical business. The Company is focused on discovering, developing, and commercializing products that address medical conditions with significant unmet needs in the areas of oncology, immunology, neuroscience, and infectious disease. The Company has a series of patented drug candidates from the discovery stage to the late clinical project, including ZEJULA, OPTUNE, QINLOCK, NUZYRA and VYVGART, and others. The Company conducts its businesses within domestic and overseas markets.

Events Timeline

(ET)

2026-04-19

13:10:00

Zai Lab's ZL-1503 Shows Significant Efficacy in Preclinical Study

2026-04-17 (ET)

2026-04-17

15:10:00

Zai Lab's Zocilurtatug Pelitecan Shows Promising Efficacy in Small Cell Lung Cancer Patients

2026-04-01 (ET)

2026-04-01

07:40:00

Zai Lab Collaborates with Amgen on Clinical Trial for zocilurtatug

2026-02-26 (ET)

2026-02-26

08:00:00

Zai Lab Reports Q4 Revenue of $127.6M

News

1.0

11:43 AMNewsfilter

Zai Lab to Host Q1 2026 Earnings Call on May 7

7.5

04-19Yahoo Finance

Zai Lab Partners with Amgen to Evaluate Lung Cancer Therapy

9.0

04-18Newsfilter

ZL-1503 Shows Promise as First-in-Class Treatment at IMMUNOLOGY2026

9.0

04-17Newsfilter

Zoci Antibody Drug Shows Promising Efficacy in Small Cell Lung Cancer

7.5

04-01seekingalpha

Zai Lab Partners with Amgen for Global Clinical Trial

7.5

04-01Newsfilter

Zai Lab Collaborates with Amgen for Clinical Trial

5 Analyst Rating

Wall Street analysts forecast ZLAB stock price to rise

4 Buy

1 Hold

0 Sell

Strong Buy

Current: 0.000

Low

25.70

Averages

47.93

High

74.00

Current: 0.000

Low

25.70

Averages

47.93

High

74.00

JPMorgan

Anupam Rama

Overweight

downgrade

$39 -> $32

AI Analysis

2026-03-18

Reason

JPMorgan

Anupam Rama

Price Target

$39 -> $32

AI Analysis

2026-03-18

downgrade

Overweight

Reason

JPMorgan analyst Anupam Rama lowered the firm's price target on Zai Lab to $32 from $39 and keeps an Overweight rating on the shares. The firm updated models in the smid-cap biotechnology space.

Cantor Fitzgerald

Overweight

downgrade

$55 -> $37

2026-02-27

Reason

Cantor Fitzgerald

Price Target

$55 -> $37

2026-02-27

downgrade

Overweight

Reason

Cantor Fitzgerald lowered the firm's price target on Zai Lab to $37 from $55 and keeps an Overweight rating on the shares. Zai Lab reported Q4 and full-year revenues of $127.6M and $460.2M, respectively, in line with consensus, though Vyvgart sales were slightly weaker than expected, the analyst tells investors in a research note. Management indicated that 2026 top-line growth is likely to be modest, with volume gains offset by pricing pressures and competition in China, the firm says.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for ZLAB

Unlock Now

Valuation Metrics

The current forward P/E ratio for Zai Lab Ltd (ZLAB.O) is 0.00, compared to its 5-year average forward P/E of -17.82. For a more detailed relative valuation and DCF analysis to assess Zai Lab Ltd's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-17.82

Current PE

0.00

Overvalued PE

3.30

Undervalued PE

-38.94

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

-13.63

Current EV/EBITDA

-6.97

Overvalued EV/EBITDA

0.34

Undervalued EV/EBITDA

-27.60

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

15.05

Current PS

4.35

Overvalued PS

33.61

Undervalued PS

-3.51

Financials

AI Analysis

Annual

Quarterly

Related Community Screener

what stock should I trade today

Intellectia · 19 candidates

Market Cap: >= 1000.00MPrice: $5.00 - $100.00Price Change Pct: >= $3.00Beta: HighRiskList Exchange: XNYS, XNAS, XASEMonthly Average Dollar Volume: >= 2,000,000

Ticker

Name

Market Cap$

PSNY

Polestar Automotive Holding UK PLC

1.21B

FORM

FormFactor Inc

5.43B

AXTI

AXT Inc

1.11B

OCUL

Ocular Therapeutix Inc

1.80B

BLBD

Blue Bird Corp

1.58B

KLIC

Kulicke and Soffa Industries Inc

2.89B

Whales Holding ZLAB

Frazier Life Sciences Management, LP

Qiming Weichuang Venture Capital Management (Shanghai) Company Limited

Maxwealth Fund Management Co., Ltd

Rock Springs Capital Management LP

Trading Trends

People Also Watch

Frequently Asked Questions

What is Zai Lab Ltd (ZLAB) stock price today?

The current price of ZLAB is 24.44 USD — it has decreased -3.21

What is Zai Lab Ltd (ZLAB)'s business?

What is the price predicton of ZLAB Stock?

Wall Street analysts forecast ZLAB stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ZLAB is47.93 USD with a low forecast of 25.70 USD and a high forecast of 74.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Zai Lab Ltd (ZLAB)'s revenue for the last quarter?

Zai Lab Ltd revenue for the last quarter amounts to 127.60M USD, increased 16.99

What is Zai Lab Ltd (ZLAB)'s earnings per share (EPS) for the last quarter?

Zai Lab Ltd. EPS for the last quarter amounts to -0.05 USD, decreased -37.50

How many employees does Zai Lab Ltd (ZLAB). have?

Zai Lab Ltd (ZLAB) has 1784 emplpoyees as of April 22 2026.

What is Zai Lab Ltd (ZLAB) market cap?

Today ZLAB has the market capitalization of 2.70B USD.

ZLAB Overview

ZLAB Overview

Events Timeline

News

Valuation Metrics

Forward PE

Forward EV/EBITDA

Forward PS

Financials

Related Community Screener

Whales Holding ZLAB

Trading Trends

People Also Watch

Frequently Asked Questions

What is Zai Lab Ltd (ZLAB) stock price today?

What is Zai Lab Ltd (ZLAB)'s business?

What is the price predicton of ZLAB Stock?

What is Zai Lab Ltd (ZLAB)'s revenue for the last quarter?

What is Zai Lab Ltd (ZLAB)'s earnings per share (EPS) for the last quarter?

How many employees does Zai Lab Ltd (ZLAB). have?

What is Zai Lab Ltd (ZLAB) market cap?